IAS 2017: HIV Prevention Roadmap

Transcription

1 Code SUSA01 SUSA04 SUSA02 SUSA06 Title Organizers Type Date Time Intervention URL Mind the Gap: Filling Knowledge Gaps in Paediatric and Adolescent HIV for an IAS/CIPHER and WHO Department of HIV AIDS Global FREE Key Generation Population Linkages Across HIV Cascade Projects and the Continuum of Analyses HIV Services for Key Populations Affected by HIV (LINKAGES) Opening the Door: Understanding the State of the HIV Epidemic through the Populationbased HIV Impact Assessment Surveys Treat All in Resource- Constrained Settings: Lessons Learned from Zimbabwe and Implications for National and Regional Roll-out of HIV Test and Treat Strategies IAS 2017: HIV Roadmap ICAP at Columbia University Organization for Public Health Interventions and Development (OPHID) & Zimbabwean Ministry of Health and Child Care :00-10: Treatment, Testing, Pediatric, Adolescents 10:15-12:15 Implementation, Treatment 10:15-12:15 General, PHIA Surveys 10:15-12:15 Treatment, Testing, "Treat All" org/programme//17 2 org/programme//16 6 org/programme//19 2 org/programme//11 6

2 SUSA10 SUSA11 SUSA07 SUSA14 SUSA18 Differentiated Care from Testing to Suppression: Are we at the Tipping Point? Non-ARV Based Interventions to Combat HIV/AIDS: New Insights and Initiatives Pre-Exposure Prophylaxis WHO (PrEP): Moving from Demonstration Projects to Wider Implementation Nonstop Journey: Delivering an Uninterrupted Continuum of HIV Services to Adolescents and Youth A More Effective Response to HIV/AIDS: the Role of Value for Money International AIDS Society (IAS) & the World Health Organization (WHO) INSERM - French National Institute of Health and Medical Research Elizabeth Glaser Pediatric AIDS Foundation ANRS, Unitaid :30-14:30 Treatment, Testing, Differentiated Care 12:30-14:30 Research, Vaccine, Cure 12:30-14:30 Implementation, PrEP, AGYW 14:45-16:45 Treatment, Testing, Adolescents 14:45-16:45 Funding in relation to, Treatment, Testing & Monitoring org/programme//94 org/programme//40 org/programme//17 6 org/programme//11 5 org/programme//16 9

3 SUSA15 SUSA17 SUSA20 SUSA22 The Next Wave of Options: An update and interactive discussion on the pipeline of injections, infusions and implants who will use, who will deliver, who will pay Better Data, Better Programmes: How Implementation is Transforming the HIV Response for Key Populations HIV Self-Testing: Evidence for Action: Key Findings from the HIV Self-Testing Africa (STAR) Project in Malawi, Zambia and Zimbabwe Future Perfect: Opportunities and Obstacles for HIV Vaccines AVAC FHI 360/LINKAGES, amfar, CDC, and USAID Unitaid/ World Health Organisation/Popu lation Services International/Lond on School of Hygiene and Tropical Medicine Global HIV Vaccine Enterprise with AVAC, Bill & Melinda Gates Foundation, Imperial College London, INSERM, MHRP, NIH :45-16:45 Research, Injectables, Implants, Infusions, PrEP 14:45-16:45 General, Testing, Treatment, PrEP, MSM, Transgender, 17:00-19:00, Testing 17:00-19:00 Vaccines org/programme//18 2 org/programme//16 8 org/programme//76 org/programme//18 7

4 SUPL01 Opening Plenary MOSA02 MOSA04 MOSA03 MOSA01 MOSA05 Making Strides with Systemic PrEP: Pills, Injection, Infusions and Implants Integrating Diagnostic Services at Point of Care Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network British HIV Association Symposium Tougher Times: Adapting to Increasing Demand with Declining Resources Highly Effective Monitoring of HIV Viral Load by Transcription Mediated Amplification A Perfect Tool for all Situations HPTN / FHI 360 Cepheid The Office of HIV/AIDS Network Coordination s Cross-Network Youth Research Working Group British HIV Association Hologic, Inc Corporate Corporate 19:30-21:00 General 7:00-8:30 PrEP, Injectables, Implants and Infusions 242 7:00-8:30 Treatment 241 7:00-8:30, PrEP, Microbicides 7:00-8:30, PrEP (Generic) 251 7:00-8:30 Treatment org/programme//29 org/programme//19 8 org/programme//17 0 org/programme//16 5 org/programme//14 9 org/programme//10 1

5 MOPL01 Monday, Plenary - - [ inlcudes "Adding D to the ABC: putting the drugs in the ABC of prevention" Sheena McCormack, University College London (UCL)] Plenary MOSY04 Translational Vaccinology Symposia MOSY03 MOAX01 Topical Agents for PrEP: As Good as Systemic PrEP? Just Do It Yourself: Preferences and Performances of HIV Selftesting Symposia Cross- Track MOAX02 Co-Chairs' Choice Cross- Track MOPDD01 Getting on with #Adolescents Poster Discussion MOPDC01 Anti-virals and Pregnancy Poster Discussion 8:45-10:30 General Blue :00-12:30 Vaccines 11:00-12:30 PrEP, Ring, Gels 11:00-12:30 Testing 11:00-12:30 PrEP, long-acting treatment 13:00-14:00 Treatment, Adolescents, Risk Perception 13:00-14:00 General, Ring org/programme//20 org/programme//16 1 org/programme//46 org/programme//12 3 org/programme//20 3 org/programme//12 9 org/programme//13 6

6 MOSY05 MOWS02 MOSY08 Fast-Track Cities: Ending AIDS in High HIV Burden Cities and Municipalities by 2030 HIV Cure in Men and Women: From Mechanisms of HIV Latency and Persistence to Potential Therapeutic Strategies On-demand Oral TDF/FTC for PrEP: Is It an Option? Symposia 14:30-16:00 Treatment, Implementation Workshop :30-17:00 Cure Symposia MOAA02 Kill Me or Neutralize Me Track A Basic MOWS04 MOAD02 mhealth and the Global HIV Response: Harnessing the Promise of Mobile Technologies for Effective Programme Implementation Unlocking the Epidemic with Key Populations Blue 16:30-18:00 PrEP 16:30-18:00 Vaccines Workshop :30-18:00, Treatment, Technology Track D Implementation 16:30-18:00 General, Testing,, Treatment org/programme//80 org/programme//25 org/programme//9 org/programme//12 7 org/programme//19 org/programme//12 2

7 MOSA12 MOSA11 Evaluating the Impact of HIV Self-Test Availability on Testing Uptake: Results from Uganda, Zambia and Kenya IAS HIV Cure & Cancer Forum: Highlights & Discussion MOSA07 Challenge to Achieve : Shedding Light on Young, Female and Noninjection Drug Users MOSA09 MOSA10 Strategies and Alternative Mechanisms for Funding HIV Research Want to Become a PrEP Jhpiego Expert? Translation of WHO PrEP Implementation Tool into Interactive elearning Resource Package (LRP) and Mobile App Resource International Initiative for Impact Evaluation (3ie) International Initiative for Impact Evaluation (3ie) Expertise France United States Centers for AIDS Research (CFARs), and United States Department of Health and Human Services, National Institutes of Health, Office of AIDS Research (OAR) :30-20:30 Testing 18:30-20:30 Cure 18:30-20:30 General 18:30-20:30 General, Funding 18:30-20:30 PrEP org/programme//37 org/programme//37 org/programme//18 5 org/programme//19 5 org/programme//41

8 TUSA04 TUSA02 TUSA03 TUSA05 Eliminating Cervical Cancer: an Urgent Need for HIV-positive Women Correlates of Reduced HIV Acquisition in Vector Prime Protein Boost HIV Vaccine Regimens Reality Check: Delivering a Holistic HIV Combination Package Twenty Years of the South African National Female Condom Programme: What We Can Learn to Inform the Future Direction of Biomedical HIV Technologies PATH HIV Vaccine Trials Network Mylan Laboratories Ltd. MatCH Research Unit (MRU), Dept of Obstetrics and Gynaecology, University of the Witwatersrand Corporate TUPL01 Tuesday, Plenary Plenary TUSY02 TUWS01 Broadly Neutralizing Antibodies against HIV Prepping Men Who Have Sex with Men for Better Health Outcomes: A Conversation between Healthcare Providers and Their Clients Symposia 7:00-8:30 General, HPV, Cervical Cancer 7:00-8:30 Vaccines 7:00-8:30 Combination, Modeling 241 7:00-8:30, Female Condom 8:45-10:30 General :00-12:30, Treatment Workshop :00-12:30 Implemetation, PrEP, MSM org/programme//18 4 org/programme//18 3 org/programme//93 org/programme//10 0 org/programme//21 org/programme//16 0 org/programme//50

9 TUAC02 and Adolescents TUAC03 Hitting the First 90 Target: Lessons from Population-based Surveys TUAC01 TUAA01 TUPDB01 TUPDC01 TUSS01 Updates from PrEP Clinical Trials The Wrestling Match: Virus Versus Immune Cells HIV Reservoirs: Ups and Downs TRANScending Barriers for Translating Impact from AIDS for Global Health Track C Track C Track C Track A Basic Poster Discussion Poster Discussion Special TUPDD01 The Missing Men Poster Discussion Blue :00-12:30 Implementation, Testing, PrEP, AGYW, Ring, Adolescents 11:00-12:30 General, DATA, PHIA 11:00-12:30 Research, PrEP, Ring 11:00-12:30 Vaccines 13:00-14:00 Cure 13:00-14:00 Implementation, Testing, PrEP, Transgender Populations 13:00-14:00 General 13:00-14:00 Implementation, VMMC, PrEP, Testing org/programme//14 3 org/programme//14 2 org/programme//13 9 org/programme//13 0 org/programme//15 4 org/programme//13 8 org/programme//15 7 org/programme//12 6

10 TUAC04 TUWS03 TUSY05 TUSA10 : It's Not Just about PrEP Changing Landscapes, Changing Gears: Differentiated Service Delivery for Adolescents Living with HIV Ending AIDS through Research Training and Capacity Building in Lowand Middle-income Countries: Lessons Learned and Future Directions HPTN Modelling Centre Symposium: Recent Advances in Mathematical Modelling to Inform HIV Research Activities and Directions HIV Trial Network (HPTN) Modelling Centre Track C Blue 14:30-16:00, PrEP, Testing Workshop :30-17:00 Treatment, Adolescents Symposia 16:30-18:00 Research Training 18:30-20:30 Research, Modelling org/programme//14 8 org/programme//51 org/programme//92 org/programme//96

11 TUSA13 WESA01 WEPL01 WEAC01 Bringing the Test to the Patient: Results from the Early Routine Use of Point-of-Care HIV Testing in Resource-Limited Settings HPTN 071 (PopART): Cross-Disciplinary Approaches to Understand Successes and Challenges of Implementing a Community-Wide Universal Test and Treat Programme in Sub- Saharan Africa Wednesday, Plenary PrEP Expectations and Experiences African Society for Laboratory Medicine (ASLM), the Clinton Health Access Initiative (CHAI), the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), UNICEF, and Unitaid HPTN 071 (PopART) Plenary Track C WEPDD01 Getting to the First 90 Poster Discussion :30-20:30 Testing Wed, 26 July 7:00-8:30 Implementation, Treatment, Testing Wed, 26 July 8:45-10:30 General Wed, 26 July 242 Wed, 26 July 11:00-12:30 PrEP, Implementation 13:00-14:00 Testing, Implementation of Self-Testing org/programme//98 org/programme//19 1 org/programme//22 org/programme//14 5 org/programme//13 1

12 WESS01 IAS Members Meeting and Joep Lange Memorial Lecture WESY04 The New $90-$90-$90: Drugs Affordable for All Special Symposia WESY06 Toward HIV Elimination Symposia WESY05 Basic Vaccinology Symposia WEWS02 How to Assess the Efficacy of New Strategies for the of HIVinfection? WEAD02 When Donors Leave... Track D Implementation WEPL02 Rapporteur and Closing Blue Amphithe ater Wed, 26 July Wed, 26 July 241 Wed, 26 July Wed, 26 July 13:00-14:30 General, HIV Research 14:30-16:00 Treatment - Costs 14:30-16:00 Testing,, Cure, VMMC 14:30-16:00 Vaccines Workshop 242 Wed, 26 July 14:30-17:00 Research Plenary Wed, 26 July Wed, 26 July 16:30-18:00 General, Funding 18:15-19:45 General org/programme//15 8 org/programme//13 org/programme//47 org/programme//6 org/programme//18 org/programme//11 9 org/programme//30